Appel à projets : PHRCN (2020)
Titre : Immediate versus delayed treatment with azathioprine or rituximab in anti-myelin oligodendrocytes glycoprotein (anti-MOG) antibodies associated acute demyelinating syndromes in children a randomized controlled clinical trial
Acronyme : IDAR
Discipline principale : Pédiatrie
Porteur : Kumaran DEIVA
Établissement : ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (CHUR), Île-de-France
Financement total : 1546074 €